Hostname: page-component-7b7567c8c-9cwtv Total loading time: 0 Render date: 2026-11-19T16:20:51.686Z Has data issue: false hasContentIssue false

Burden of death associated with SARS-CoV-2 infection during the pandemic in Flint, Michigan (MI), mortality trends over the 2-year period: impact of social and health inequities

Published online by Cambridge University Press:  07 August 2024

Mariam Younas*
Affiliation:
Department of Medicine, Hurley Medical Center, Flint, MI, USACollege of Human Medicine, Department of Medicine, Michigan State University, East Lansing, MI, USA
Danielle Osterholzer
Affiliation:
Department of Medicine, Hurley Medical Center, Flint, MI, USACollege of Human Medicine, Department of Medicine, Michigan State University, East Lansing, MI, USA
Carlos F. Ríos-Bedoya
Affiliation:
Department of Medicine, Hurley Medical Center, Flint, MI, USACollege of Human Medicine, Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USAMcLaren Health Care, Graduate Medical Education, Grand Blanc, MI, USA
*
Corresponding author: Mariam Younas; Email: drmariamyounas@gmail.com

Abstract

Background:

This cross-sectional study aims to determine the mortality trends in patients with SARS-CoV-2 infection during the pandemic in Flint, MI.

Methods:

Records from 1,663 consecutive adult patients (≥18 years of age) with confirmed SARS-CoV-2 infection, admitted and discharged from our facility from 03/2020 through 02/2022, were abstracted and analyzed. Multivariable logistic regression analysis was performed to examine the association between study explanatory variables (ie, sex, age, co-morbidities, etc.) and the primary study outcome (ie, mortality).

Results:

During the 2-year study period, the overall crude 90-day mortality rate was 16.1% (267/1663), being lowest in the period 5 (Table 1). Male sex, older age, certain co-morbidities, supplemental oxygenation use, and lack of immunization were associated with mortality. Therapeutics such as remdesivir and steroids were not associated with improved survival.

Conclusion:

Despite substantial changes in supportive care, management and circulating variants, SARS-CoV-2 carried a significant mortality risk. Vaccination coverage in this high-risk study sample was low, at only 12%. Public health efforts should be focused at overcoming the barriers to vaccine acceptance in this high-risk unique population.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Characteristics of individuals with SARS-CoV-2 infection during the first and subsequent waves of the pandemic, immunization against COVID-19 and use of COVID-19 therapeutics in Flint, MI

Figure 1

Figure 1.Institutional protocol.

Figure 2

Table 2.Type of monoclonal antibodies administered – time line at Hurley

Figure 3

Table 3.Comparative mortality based on race and predominant SARS-CoV-2 circulating strain

Figure 4

Table 4.Co-morbidities and outcomes

Figure 5

Figure 2.Detailed map of Flint and surrounding areas COVID-19 vaccine status (as of 08/20/2023). Numbers on the maps are the census tracts for each location. The percent population receiving the vaccination is indicated by the legend/color. Yellow star highlights the approximate location of Hurley Medical Center. “Up to Date” refers to individuals who have received the latest recommended dose based on current public health guidance for their age group. www.gchd.us.